Drug offers hope for rheumatoid arthritis sufferers
Sufferers of rheumatoid arthritis have been given hope of a new drug that may stop the condition. RoActemra, administered monthly through injections, has been indicated by trial data to work alongside an existing treatment, methotrexate, to stop the condition in which the body begins attacking its own joints. However, the combination of the two drugs, the former of which will be manufactured by Roche, does nothing to reverse the effects of the condition. The treatment was trialled using 1,190 patients. In those taking both medications, rheumatoid arthritis was halted in just under half ...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
